Skip to main content
. 2010 Oct 25;432(Pt 1):9–19. doi: 10.1042/BJ20100308

Figure 3. MitoQ protects against diabetic glomerular dysfunction in Ins2+/−AkitaJ mice as determined by the 99mTc-DTPA clearance.

Figure 3

(A) Representative real-time images of the whole animal at various time points during the study are shown. (B) Means±S.E.M. (n=4–6) of the profiles demonstrating the uptake and clearance phases of the 99mTc–DTPA radioactive tracer in the right kidney after injection through the tail vein by analysing the real-time images from non-diabetic wild-type (WT) and diabetic Ins2+/−AkitaJ mice (Akita), with (MitoQ) or without (Ctrl) MitoQ treatment.